Lynx1 regulates synaptic plasticity in the brain by regulating nicotinic acetylcholine receptors (nAChRs). It is not known to which extent Lynx1 can bind to endogenous nAChR subunits in the brain or how this interaction is affected by Alzheimer's disease pathology. We apply affinity purification to demonstrate that a water-soluble variant of human Lynx1 (Ws-Lynx1) isolates a3, a4, a5, a6, a7, b2, and b4 nAChR subunits from human and rat cortical extracts, and rat midbrain and olfactory bulb extracts, suggesting that Lynx1 forms complexes with multiple nAChR subtypes in the human and rodent brain. Incubation with Ws-Lynx1 decreases nicotine-mediated extracellular signaleregulated kinase phosphorylation in PC12 cells and striatal neurons, indicating that binding of Ws-Lynx1 is sufficient to inhibit signaling downstream of nAChRs. The effect of nicotine in PC12 cells is independent of a7 or a4b2 nAChRs, suggesting that Lynx1 can affect the function of native non-a7, non-a4b2 nAChR subtypes. We further show that Lynx1 and oligomeric b-amyloid 1e42 compete for binding to several nAChR subunits, that Ws-Lynx1 prevents b-amyloid 1e42 einduced cytotoxicity in cortical neurons, and that cortical Lynx1 levels are decreased in a transgenic mouse model with concomitant b-amyloid and tau pathology. Our data suggest that Lynx1 binds to multiple nAChR subtypes in the brain and that this interaction might have functional and pathophysiological implications in relation to Alzheimer's disease.
Introduction
Ly-6/neurotoxin (Lynx) protein Lynx1 is a glycophosphatidylinositol-anchored membrane protein that is structurally similar to the snake toxin a-bungarotoxin (Miwa et al.,1999) , a potent inhibitor of muscle-type and a7 nicotinic acetylcholine receptors (nAChRs) (Tsetlin et al., 2009 ). In line with this, Lynx1 has been shown to form complexes with and negatively modulate the response of a7 and a4b2 nAChRs in heterologous expression systems (Fu et al., 2012; Ibañez-Tallon et al., 2002) . Lynx1 is expressed in both glutamatergic and g-aminobutyric acid-ergic (GABAergic) neurons in the brain (Demars and Morishita, 2014) . Lynx protein is enriched on the cell membrane and in synapses (Thomsen et al., 2014) , and Lynx1, acting through nAChRs, is critical for the loss of synaptic plasticity in the visual cortex that occurs during postnatal development (Morishita et al., 2010) . These results suggest that Lynx1 can modulate nAChR function in the brain with important consequences for cholinergic-dependent synaptic plasticity [reviewed in (Miwa et al., 2011 (Miwa et al., , 2012 Thomsen and Mikkelsen, 2012) ].
Alzheimer's disease (AD) pathology is characterized by plaques and neurofibrillary tangles containing aggregated b-amyloid (Ab) and hyperphosphorylated tau protein, respectively (Querfurth and LaFerla, 2010) . Soluble Ab species, particularly oligomeric Ab 1e42 , are considered to be the most toxic form of Ab and are associated with cognitive deficits in AD (Lue et al., 1999; Walsh and Selkoe, 2007) . Interestingly, soluble Ab 1e42 interacts with and regulates the function of several nAChR subtypes (Dougherty et al., 2003; Lamb et al., 2005; Pettit et al., 2001; Wang et al., 2000; Wu et al., 2004) . Although it remains to be established exactly how Ab 1e42 and nAChRs interact and whether Ab 1e42 produces positive or negative modulation of nAChR function [reviewed in (Buckingham et al., 2009; Parri and Dineley, 2010) ], it has been convincingly demonstrated that nAChR activation blocks Ab-mediated neurotoxicity in vitro (Kihara et al., 1997 (Kihara et al., , 2001 Takada-Takatori et al., 2006) . Furthermore, the a7 nAChR has been shown to facilitate intracellular accumulation of Ab 1e42 in vitro (Nagele et al., 2002) , and reducing the interaction between Ab 1e42 and the a7 nAChR increases clearance of Ab 1e42 in mice after intracerebroventricular infusion of Ab 1e42 (Wang et al., 2010) . Moreover, crossing a7 nAChR knockout mice (KO) with mice overexpressing amyloid precursor protein (APP) leads to increased Ab production and affects memory deficits as well as neuropathology in APP-a7 KO mice (Dziewczapolski et al., 2009; Hernandez et al., 2010) . In addition, binding of the a4b2 nAChR radioligand 18 F-2FA-85380 was decreased in several brain regions of AD patients, and this decrease correlated with Ab load and cognitive performance in the medial prefrontal cortex (Okada et al., 2013) . Combined with the observation that cholinergic neurons degenerate and nAChR levels are decreased in AD (Auld et al., 2002; Marutle et al., 2013; Okada et al., 2013) , the aforementioned results suggest that the interaction between nAChRs and Ab 1e42 affects cognitive function and may be involved in the pathophysiology of AD.
Here, we investigate the ability of a previously characterized recombinant soluble variant of human Lynx1 (Ws-Lynx1) (Lyukmanova et al., , 2013 , to bind and regulate native nAChRs in human cortical extracts and PC12 cells, respectively. We further examine whether Ws-Lynx1 modulates the interaction between oligomeric Ab 1e42 and nAChRs.
Materials and methods

Human tissue and animals
Human temporal neocortical tissue was obtained from an anterior temporal resection performed in a patient (female, age 44) with medically intractable temporal lobe epilepsy with hippocampal onset. Written informed consent was obtained before surgery. The study was approved by the Ethical Committee in the Capital Region of Denmark (H-2-2011-104) and performed in accordance with the Declaration of Helsinki. The tissue was immediately frozen on dry ice and stored at À80 C until use. The neuropathological examinations of the neocortex revealed no abnormalities.
Four adult male Sprague-Dawley rats (210e223 g) were obtained from Charles River Laboratories (Sulzfeld, Germany) and housed 2 per cage. Animals were kept on a 12:12-hour light:dark cycle provided with standard rodent diet and water ad libitum. The animals were acclimatized for a minimum of 7 days after arrival before experiments began. They were decapitated, and the frontal cortex, olfactory bulbs, and the lower part of the midbrain containing the ventral tegmentum and substantia nigra were dissected. Samples were pooled for further processing and stored at À80 C.
Triple transgenic mice (3ÂTg-AD) mice, expressing mutant human transgenes (APP 695 with the Swedish double mutation K670N/M671L [hAPPSwe] and tau P301L) and the presenilin-1 mutant M146 V knockin construct (Oddo et al., 2003) were decapitated at 6 months (n ¼ 8) or 19e21 months (n ¼ 8) of age, with age-matched wild-type (WT) mice (Sv129/B6; n ¼ 7e8) as controls. The frontal cortex was dissected and immediately frozen on dry ice and stored at À80 C until use. Data from these extracts have also been used in another article .
Affinity purification
Two proteins were used as bait for affinity purification: A recombinant water-soluble variant of human Lynx1 containing amino acids 1e73 (ws-Lynx1), expressed in Escherichia coli and purified as previously described was dissolved to 2 mg/mL in phosphate-buffered saline (PBS), pH 7.4, at 4 C for 72 hours. Preparation of oligomeric Ab 1e42 and the reverse peptide Ab 42e1 was performed according to the study by Stine et al. (2003) . Briefly, Ab 1e42 or Ab 42e1 (SigmaeAldrich) were dissolved to 1 mM in ice-cold 1,1,1,3,3,3-hexafluoro-2-propanol, evaporated, and stored at À20 C. Before use, 100 mg aliquots were resuspended in 4.4 mL dimethyl sulfoxide (DMSO), vortexed, and diluted to 200 mM in PBS followed by incubation for 24 hours at 4 C to form oligomeric amyloid. Ws-Lynx1 or oligomeric Ab 1e42 were coupled to PureProteome NHS Flexibind magnetic beads (Millipore, Billerica, MA, USA) in a ratio of 1:2 (v/v) using the manufacturer's instructions. Successful coupling was confirmed by subsequent protein determination showing more than 50% decrease in the protein content of the solution. Another batch of beads was processed in parallel but treated with PBS devoid of bait protein as a negative control. The beads were incubated in 0.1% bovine serum albumin in PBS, pH 7.4 1 hour at 4 C before use.
The tissue was lysed in 1 mL lysis buffer (50 mM Tris, 50 mM NaCl, 5 mM EDTA, 5 mM ethylene glycol-bis(b-aminoethyl ether)-N,N,N 0 ,N 0 -tetraacetic acid (EGTA), 10 mL/mL protease inhibitor cocktail [SigmaeAldrich, Brøndby, Denmark], pH 7.5) using a PT1200C polytron blender (Kinematica, Luzern, Switzerland) for 20 seconds. The lysate was centrifuged 30 minutes at 160,000 Â g at 20 Ce22 C using an air-driven ultracentrifuge (Airfuge, Copenhagen, Denmark), and the supernatant discarded. The pellet was resuspended in 1 mL lysis buffer containing 2% Triton X-100 by blending for 20 seconds and incubated 2 hours at 4 C on a rotor (15 rpm). Thereafter, the sample was centrifuged as previously mentioned, and the resulting supernatant was used for affinity purification. Total protein content was determined using the Pierce 660 nm Protein Assay (Thermo Scientific, Rockford, IL, USA), and 500e1000 mg of protein was incubated with 50 mL magnetic beads in a total volume of 1500 mL lysis buffer for 18e22 hours at 4 C on a vertical rotor (15 rpm). Subsequently, the beads were washed twice in 1-M NaCl, 8 mM Na 2 HPO 4, 2 mM NaH 2 PO 4 , 0.5% Triton X-100, pH 7.5 and 3 times in 0.1-M NaCl, 8 mM Na 2 HPO 4, 2 mM NaH 2 PO 4 , 0.5% Triton X-100, pH 7.5 and immediately processed for Western blotting.
For experiments including preincubation with Ab 1e42 or Ab 42e1 , tissue extracts were homogenized and split into 2 aliquots. 1.5 mL of 200 mM oligomeric Ab 1e42 or Ab 42e1 or vehicle (4% DMSO in PBS) was added to the respective aliquots followed by incubation for 60 minutes on ice before addition of beads. The experiment with Ws-Lynx1 preincubation was performed by addition of 100 mL 50 mM Ws-Lynx1 or vehicle in a total volume of 500 mL.
Western blotting
Total protein content was measured using a DC Protein Assay Kit (Biorad, Hercules, CA, USA). Equal amounts of lysates were then diluted in loading buffer (120 mM Tris, 20% [v/v] glycerol, 10% [v/v] mercaptoethanol, 4% [w/v] sodium dodecyl sulphate, and 0.05% [w/v] bromophenol blue, pH 6.8), incubated for 5 minutes at 95 C and submitted to gel electrophoresis using AnykD gels (Biorad), and blotted onto polyvinylidene fluoride membranes (BioRad). Membranes were washed in tris-buffered saline with 0.1% Tween 20 (TBS-T) and blocked in TBS containing 5% (w/v) dry milk powder, which was also used for antibody incubations. Incubation with primary antisera directed against Lynx1 (1:1000, #sc-23060, Santa Cruz Biotechnology, Heidelberg, Germany); b2 (1:1000, kindly provided by Dr Cecilia Gotti); a3, a4, a5, a6, and 5-HT 3
(1:100 #sc-1771, sc-5591, sc-28795, sc-27292, and sc-28958 Santa Cruz Biotechnology); a7, b4 (1:1000 #ab23832 and 1:100 #ab156213 Abcam, Cambridge, UK); Actin (1:10,000, #A5060, SigmaeAldrich); pERK1/2 (1:4000 #9101 Cell Signaling, Leiden, The Netherlands); or ERK1 (1:4,000, #610031, BD Transduction Laboratories, Franklin Lakes, NJ, USA) was performed overnight at 4 C on parafilm in a humidified container, followed by 3 Â 10 minute washes in TBS-T and 1 hour incubation at 20 Ce22 C with horseradish peroxidase-conjugated secondary antibody (1:2000, Dako, Glostrup, Denmark). After thorough washing in TBS-T, enhanced chemiluminescence Western blotting detection reagents (Western Lightning ECL Pro, Perkin Elmer, Waltham, MA, USA) were used for signal detection, and protein bands were visualized using a Chemidoc XR digital image analyser (Biorad). In the experiments with minced slices, total protein content as measured by Stain-Free technology (Biorad) was used to normalize band intensity. Mean optical densities of bands were measured and their corresponding background measurement subtracted. Molecular weights were estimated by comparing with dyed protein markers (PageRuler Prestained Protein Ladder, Thermo Scientific).
PC12 cell culturing and ERK phosphorylation assay
PC12 cells were maintained in 75 cm 2 flasks coated with 5 mg/mL poly-L-lysine (SigmaeAldrich, Brøndby, Denmark), in Dulbecco's modified Eagle medium (DMEM, Gibco Life Technologies, NY, USA) supplemented with 10% heat inactivated horse serum, 5% fetal bovine serum, 25-U/mL penicillin, 25 mg/mL streptomycin, 1 mM sodium pyruvate, and 2 mM glutamine at 37 C in a humidified incubator with 5% CO 2 . Cells were subcultured every 3e4 days by detachment with 0.25% trypsin in EDTA solution (Life Technologies, NY, USA) and re-seeded at 15% confluence.
For the extracellular signaleregulated kinase (ERK) phosphorylation assay, cells were seeded in 24-well plates at 12 Â 10 4 cells/ cm 2 , 24 hours before the experiment. On the day of the experiment, cells were incubated for 10 minutes with Ws-Lynx1, mecamylamine (SigmaeAldrich), dihydro-b-erythroidine (DhbE, Tocris Bioscience, Bristol, UK), methyllycaconitine (MLA, Santa Cruz Biotechnology), or the a-conotoxins AuIB, PIA, or MII (Tocris) diluted in DMEM, followed by 5 minutes stimulation with 25 mM nicotine (SigmaeAldrich). Thereafter, cells were lysed in 100 mL ice-cold lysis buffer/well (100 mM NaCl, 25 mM EDTA, 10 mM Tris, 4 mM Na 3 VO 4 ,
, pH 7.4). To ensure complete lysis, lysates were then placed at À80 C for 15 minutes, thawed, and sonicated for 5 seconds on ice. Lysates were stored at À80 C until use.
ERK phosphorylation in minced slices
Frontal cortex and striatum were dissected from 4 male Wistar rats (Charles River, Germany) weighing 200e300 g, chopped with 150 mm intervals 3 times with a 60-degree rotation in between using a tissue chopper (Brinkman Instruments, Westbury, NY, USA). The resulting minced slices were resuspended in 37 C Krebs buffer (KB: 118 mM NaCl, 2.4 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 KH 2 PO 4 , 25 mM NaHCO 3 , 10 mM D-glucose, oxygenated with 95% O 2 /5% CO 2 for 1 hour, pH 7.4) and triturated 10 times to further dissociate the tissue. Slices were washed in KB and incubated at 37 C for 30 minutes while shaking. About 90 mL of the resuspended minced slices was added to tubes containing 10 mL of vehicle (KB), nicotine, Ws-Lynx1, and nicotine or KCl and incubated for another 5 minutes at 37 C with vigorous shaking. Then, 100 mL of lysis buffer (radioimmunoprecipitation assay buffer) with 8% b-mercaptoethanol and 4% sodium dodecyl sulphate, 1 mL/mL protease inhibitor cocktail, 4 mM Na 3 VO 4 , 1 mM NaF was added, and the samples were quickly frozen to À80 C to lyse the cells further, thawed and submitted to gel electrophoresis and Western blotting. To ensure uniformity, 1 set of samples were processed in parallel. Therefore, repeated measures analysis of variance (ANOVA) was used for statistical calculations.
2.6. Messenger RNA (mRNA) extraction and quantitative PCR (qPCR) Total RNA was isolated using an RNeasy Mini Kit (Qiagen, Copenhagen, Denmark) according to the manufacturer's instructions. RNA samples were dissolved in RNase-free water, and RNA content was quantified using a Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). Samples were diluted with RNase-free water to equal RNA concentrations and reverse transcribed into single-stranded complementary DNA (cDNA) with the ImProm-II Reverse Transcription System (Promega, Madison, WI, USA) according to the manufacturer's directions using 0.5 mg/reaction oligo(dT) 15 primers, 6 mM MgCl 2 , and 20 units of RNase inhibitor. Real-time qPCR reactions were performed in a total volume of 20 mL, containing 1 mL sample cDNA, 1 Â Brilliant II SYBR Green QPCR Master Mix (Stratagene, La Jolla, CA, USA), and 15 pmol each of the forward and reverse primers (DNA Technology, Aarhus, Denmark). Primers used were for the following transcripts:
GAPDH, a2, a3, a4, a5, a6, a7, a9, b2, b3, and b4. Primer sequences can be found in Table S1 . PCR was performed on a Light Cycler 480 Real-Time PCR System (Roche, Indianapolis, IN, USA) with a 10-minute preincubation at 94 C followed by 40 cycles of 30 seconds at 94 C, 45 seconds at 60 C, and 90 seconds at 72 C. Primer pairs were validated by using serially diluted cDNA to establish a standard curve and by confirming the existence of a single product on a gel at the correct molecular weight. Quantification of mRNA expression was performed according to the comparative C T method as described by Schmittgen and Livak (2008) . For each sample, the amount of target mRNA was normalized to the amount of GAPDH.
Cortical neurons and cytotoxicity assay
Cultures of cortical neurons were prepared from E15 mouse fetuses, according to a previously published protocol (Walls et al., 2014) . Neurons were seeded at 250,000 cells per well in 96-well plates. At days in vitro 6, the medium was exchanged for DMEM AE 0.01e10 mM Ws-Lynx1. After 2 hours, 20 mM oligomeric Ab 1e42 or vehicle (4% DMSO in DMEM) was added, and the cells were incubated for an additional 24 hours. The release of cytoplasmic lactate dehydrogenase (LDH) into the culture medium was analyzed using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega, San Luis Obispo, CA, USA), according to the manufacturer's instructions. Briefly, the culture medium was removed and spun to remove cellular residue. Then, 50 mL of a 1:10 dilution of each sample was incubated with 50 mL of a substrate mix for 30 minutes in the dark after which the reaction was stopped by addition of 50 mL of 1-M acetic acid. Finally, the color intensity was measured at 490 nm using a plate reader. A parallel group of wells were lysed by addition of Triton X-100 (final concentration 2%) to get the total LDH content of the cells. The results are presented as the ratio of LDH released compared with the total amount of LDH from the medium and the cells.
Statistical analysis
Data sets that passed Bartlett's test for standard deviations were analyzed using 2-way ANOVA followed by Tukey's multiple comparisons test, 1-way or repeated measures ANOVA followed by Dunnett's multiple comparisons test, ratio paired or unpaired t-tests. Otherwise, the KruskaleWallis test followed by Dunn's multiple comparisons test was used. The statistical calculations were performed using GraphPad Prism version 6 for Windows (GraphPad Software, San Diego, CA, USA). All data are presented as mean AE standard error of the mean, and a p-value of less than 0.05 was considered statistically significant.
Results
Ws-Lynx1 binds to multiple nAChR subtypes in human and rat brain extracts
To determine whether Ws-Lynx1 could bind native nAChR subunits, we performed affinity purification using bead-coupled Ws-Lynx1 as bait. Ws-Lynx1 was able to isolate the a3, a4, a5, a6, a7, b2, and b4 nAChR subunits in extracts from human temporal cortex (Fig. 1A) as well as in extracts from rat neocortex, midbrain, and olfactory bulbs (Fig. 1B) . Ws-Lynx1 did not isolate subunits of the closely related 5-HT 3 receptor in any of the extracts. None of the subunits were detected when the affinity purification was performed using noncoupled beads, confirming that isolation of nAChR subunits was attributable to a specific interaction with Ws-Lynx1.
The detection of the a7, b2, and b4 subunits was validated by showing that these subunits were not detected after Ws-Lynx1 affinity purification on cortical extracts from their respective knockout mice (Fig. S1 ).
Ws-Lynx1 affects the function of non-a7, non-a4b2 nAChRs in rat PC12 cells
About 25 mM of nicotine induced phosphorylation of the MAP kinase ERK in PC12 cells. Preincubation with Ws-Lynx1 at 0.1e10 mM dose-dependently reduced the nicotine-mediated increase in ERK phosphorylation, reaching significance at 10 mM (53% reduction, p < 0.001, Fig. 2A and B) .
The effect of nicotine was also abolished by preincubation with 1 and 10 mM of the nAChR pore blocker mecamylamine (p < 0.01 and p < 0.001, respectively) and by the a-conotoxin AuIB, which selectively inhibits a3b4-containing nAChRs (Luo et al., 1998) , but neither by 1 or 10 mM DhbE nor by 10 or 100 nM MLA, which are selective for a4b2 and a7 nAChRs, respectively and neither by the a-conotoxins PIA nor MII that selectively inhibit a6-or a3b2-containing nAChRs, respectively (Cartier et al., 1996; Dowell et al., 2003) (Fig. 2C) . Real-time qPCR on extracts from PC12 cells revealed the presence of the nAChR subunits a2-7, a9, and b2-4, although the degree of expression varied 43-fold from a3 with the highest expression to a4 with the lowest expression (Fig. 2D) .
Ws-Lynx1 reduces nicotine-induced ERK phosphorylation in striatal slices
25 mM nicotine significantly induced ERK phosphorylation in acutely dissociated minced slices from rat frontal cortex and striatum (22%, p < 0.05 and 13%, p < 0.05 increase compared to vehicle).
Ws-Lynx1 at 0.1e10 mM did not affect the nicotine-mediated increase in ERK phosphorylation in frontal cortical slices, but dose-dependently reduced it in striatal slices, reaching significance at 10 mM (98% reduction, p < 0.01, Fig. 3 ).
Ab 1e42 and Ws-Lynx1 compete for binding to nAChRs in rat cortical extracts
Preincubation of rat frontal cortical extracts with 200 nM oligomeric Ab 1e42 significantly reduced the amount of a3 (23%, p < 0.05), a4 (20%, p < 0.05), a5 (25%, p < 0.05), and a7 (15%, p < 0.05) nAChR subunits that were isolated by affinity purification with Ws-Lynx1 ( Fig. 4A and B) , compared with parallel samples affinity purified in the absence of Ab 1e42 . Ab 1e42 did not significantly alter the purification of a6, b2, or b4 nAChR subunits. Fig. 1 . Ws-Lynx1 binds multiple nAChR subunits in the human and rat brain. Affinity purification was performed using magnetic beads covalently coupled with recombinant soluble human Lynx1 (Lynx1) or noncoupled beads (Ctrl) on homogenates (Hom) from (A) human temporal cortex and (B) rat cortex (CTX), lower part of the midbrain containing the ventral tegmentum and substantia nigra (VTA/SN) and olfactory bulb (OLF). Samples were submitted to gel electrophoresis and Western blotting followed by detection of nAChR subunits and the 5-HT 3 receptor. Abbreviation: nAChR, nicotinic acetylcholine receptor.
Preincubation with 200 nM of the reverse peptide, Ab 42e1 , did not affect the amount of any of the measured nAChR subunits purified using Ws-Lynx1 (Fig. 4C) .
We found that bead-coupled oligomeric Ab 1e42 was able to isolate all the nAChR subunits assayed (Fig. 4D) . Further, preincubation with 10 mM Ws-Lynx1 significantly reduced the amount of a4 (23%, p < 0.05), a7 (30%, p < 0.05), and b2 (32%, p < 0.05) nAChR subunits that were isolated by affinity purification with oligomeric Ab 1e42 ( Fig. 4D and E) . Ws-Lynx1 did not significantly alter the purification of a3, a5, a6, or b4 nAChR subunits.
Affinity purification with Ws-Lynx1 from pure solutions of 200 nM oligomeric Ab 1e42 did not yield detectable isolation of Ab 1e42 (Fig. S2) .
Ws-Lynx1 prevents Ab 1e42 -induced cytotoxicity in vitro
Incubation of mouse cortical neurons with 20 mM oligomeric Ab 1e42 for 24 hours significantly increased the amount of LDH released into the media from the neurons (Fig. 5 ). This effect of Ab 1e42 was significantly reduced by preincubating the neurons with 0.1 and 10 mM Ws-Lynx1 for 2 hours (p < 0.05 and p < 0.01, respectively).
Lynx1 levels are reduced in transgenic mice with amyloid and tau pathology
Lynx1 levels were measured in the frontal cortex of 6 or 19 to 21-month-old 3ÂTg-AD mice compared with age-matched WT mice (Fig. 6) . A 2-way ANOVA revealed a significant main effect of both genotype and age (both p < 0.05), indicating that 3ÂTg-AD mice have significantly lower Lynx1 levels compared with WT mice and that 19 to 21-month-old mice had significantly higher Lynx1 levels compared with 6-month-old mice. Subsequent multiple comparisons revealed a significantly lower level of Lynx1 in 19 to 21-month-old 3ÂTg-AD mice compared with age-matched WT mice (p < 0.01).
Discussion
Our main findings are that Ws-Lynx1 forms complexes with multiple native nAChR subunits in human brain extracts and that Ab 1e42 and Ws-Lynx1 compete for binding to nAChRs.
Lynx1 protein has attracted attention because it was shown that murine Lynx1 co-immunoprecipitates with and inhibits the function of a7 and a4b2 nAChRs in heterologous expression systems (Ibañez-Tallon et al., 2002) . However, it has remained unclear whether this was also true for native nAChRs and whether Lynx1 interactions were limited to a7 and a4b2 nAChRs. Here, we apply affinity purification with Ws-Lynx1 to show that it forms complexes with nAChRs containing a3, a4, a5, a6, a7, b2, and b4 nAChR subunits in extracts from human cortex as well as rat cortex, midbrain, and olfactory bulb. This is in stark contrast to the related Lynx protein, SLURP-1, which we have recently shown to selectively form complexes with the a7 subunit in human cortical extracts (Lyukmanova et al., 2016) and opens the possibility that Lynx1 can modulate a wide range of nAChR-dependent signaling in the human brain.
We have previously shown that a7b2 nAChRs remain intact during the affinity purification assay used here . We therefore believe it is unlikely that nAChRs are dissociated into individual subunits during the affinity purification. Our data therefore do not necessarily imply that Ws-Lynx1 binds directly to all these subunits. Rather, isolation of individual subunits can occur so long as they are part of an nAChR subtype that is able to bind to Ws-Lynx1.
To investigate the effect of Ws-Lynx1 on nAChR-mediated signaling, we used nicotine-induced phosphorylation of ERK in PC12 cells as a model system. We found that nicotine-induced phosphorylation of ERK was not sensitive to MLA or DhbE, suggesting that it was not due to activation of a7 or a4b2 nAChRs, receptors which Lynx1 has previously been shown to interact with.
Rather, it was almost completely blocked by a-conotoxin AuIB, suggesting that the effect of nicotine on ERK phosphorylation in PC12 cells it is mainly caused by activation of a3b4 nAChRs. This is in line with a previous report (Nakayama et al., 2006) . In accordance with a role for Lynx1 as a regulator of multiple nAChR subtypes, Ws-Lynx1 inhibited nicotine-mediated phosphorylation of ERK in PC12 cells.
This suggests that Lynx1 also regulates non-a7, non-a4b2 nAChR subtypes, and that inhibition by Lynx1 is sufficient to inhibit nAChR-mediated activation of the MAP kinase pathway, which is important for LTP formation and memory function (Adams and Sweatt, 2002) . We further show that Ws-Lynx1 is able to inhibit The response in striatal, but not frontal cortical slices, is reduced by preincubation with 10 mM recombinant soluble human Lynx1 (Ws-Lynx1). Values are presented as the ratio between phosphorylated (pERK) and total protein content and normalized to the degree of induction by 16 mM KCl (set to 100) and vehicle (set to 0), n ¼ 8. nicotine-induced ERK phosphorylation in striatal, but not frontal cortical, minced slices. Because the frontal cortex predominantly expresses nAChRs of the a7 and a4b2 subtypes, whereas the striatum has a more diverse pattern of expression (Gotti et al., 2006) , this suggests that Ws-Lynx1 may affect non-a7, non-a4b2 nAChR subtypes in the striatum. Notably, it has previously been shown that Lynx1 modulates a7 and/or a4b2 nAChRs in the visual cortex of mice in vivo (Morishita et al., 2010) . The micromolar concentration required for the inhibitory function of Ws-Lynx1 in PC12 cells is in line with the concentration of Ws-Lynx1 required to inhibit current flow through a7 and a4b2 nAChRs expressed in Xenopus oocytes . Our experiments involve addition of soluble Ws-Lynx1 for relatively short time to intact cells and therefore likely reflect an effect on membrane surface nAChRs. In N2a cells, Lynx1 was recently reported to associate with a4b2 nAChRs in the endoplasmic reticulum, where it affected assembly of these receptors and reduced the sensitivity to acetylcholine (Nichols et al., 2014) . Notably, these effects did not seem to involve surface expression of Lynx1 as they were not affected by cleaving surface glycophosphatidylinositol anchors (Nichols et al., 2014) . In another recent report, the Lynx proteins Lynx2 and Ly6H were shown to regulate a7 nAChR surface activity by retaining a7 nAChRs inside cells (Puddifoot et al., 2015) . It thus seems that Lynx proteins may affect nAChRs both by acting as chaperones and as regulators of nAChR function at the cell surface.
It has previously been demonstrated that Ws-Lynx1 modulates the activity of human a7 and a4b2 nAChRs, without inhibiting binding of a-bungarotoxin to a7 nAChRs or epibatidine to a4b2 nAChRs expressed in GH4C1 and SH-EP1 cells, respectively, . These data indicate that Ws-Lynx1 binds outside of the orthosteric binding site on these neuronal nAChR subtypes. Nevertheless, site-directed mutagenesis and computer modeling suggest that the binding site for Ws-Lynx1 is close to the orthosteric binding site on the a7 nAChR (Lyukmanova et al., 2013) . Ab 1e42 is believed to bind the orthosteric binding site on the a7
nAChR (Maatuk and Samson, 2013) . Therefore, we hypothesized that Ab 1e42 would be able to interfere with Lynx1-nAChR interactions [reviewed in Thomsen et al. (2016) a7b2 nAChRs with the same sample preparation , one possible explanation is that the pentameric organization of nAChRs may be disrupted during sample preparation and that Ws-Lynx1 binds to individual subunits rather than the entire nAChR containing both a and b subunits. Bead-coupled oligomeric Ab 1e42 was able to isolate a3, a4, a5, a6, a7, b2, and b4 subunits from rat cortical extracts. This extends previous findings demonstrating that Ab 1e42 interacts with a7, a4b2, a4a5b2 nAChRs (Dougherty et al., 2003; Lamb et al., 2005; Pettit et al., 2001; Wang et al., 2000; Wu et al., 2004) . Further, Ws-Lynx1 inhibited the interaction of oligomeric Ab 1e42 with a4, a7, and b2 nAChRs. The difference between the relative competition of soluble Ws-Lynx1 and oligomeric Ab 1e42 likely reflects a difference in their relative affinity toward the respective nAChR subunits. It has been suggested that physiological levels of Ab 1e42 provide a trophic signal through nAChRs, but that this is blocked or becomes toxic with excess levels of Ab 1e42 , such as those found in AD (Parri and Dineley, 2010) . Because Ws-Lynx1 and Ab 1e42 compete for binding to nAChRs, endogenous Lynx1 may be able to diminish the detrimental effects of excess Ab 1e42 seen in AD by reducing the sensitivity of nAChRs for Ab 1e42 . In line with this, we show that Ws-Lynx1 prevents Ab 1e42 -induced cytotoxicity in mouse cortical neurons.
In the frontal cortex of 3ÂTg-AD mice, which display both increased Ab levels and tau hyperphosphorylation (Oddo et al., 2003) , we found decreased Lynx1 protein levels compared with age-matched WT mice. This is in contrast to another Lynx protein, prostate stem cell antigen, that we have recently found to be upregulated in postmortem frontal cortex of patients with AD .
It is conceivable that a lower availability of Lynx1 protein promotes Ab 1e42 -nAChR interactions in this animal model of AD. In this regard, it is noteworthy that Lynx1 KO mice display nAChRdependent neuronal degeneration with age (Kobayashi et al., 2014; Miwa et al., 2006) , suggesting that Lynx1 has a neuroprotective role by dampening excess activation of nAChRs.
In summary, we hypothesize that in AD a combination of excess Ab 1e42 and decreased Lynx1 levels may act in concert to confer Ab 1e42 -mediated toxicity through nAChRs. Notably, a7 nAChRs have been shown to facilitate intracellular accumulation of Ab 1e42 (Nagele et al., 2002) , and intracellular Ab has been shown to trigger cognitive deficits in 3ÂTg-AD mice (Billings et al., 2005) . Dissociating Ab-nAChR interactions, such as with Lynx1, may therefore ameliorate the cognitive deficits seen in AD.
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